Science Advisory Committee on Chemicals Basic Information
About the SACC
The Science Advisory Committee on Chemicals (SACC) is established under the authority of the Frank R. Lautenberg Chemical Safety for the 21st Century Act, Pub. L. No. 114-182, 130 Stat. 448 (2016), and is comprised of experts in:
- toxicology;
- environmental risk assessment;
- exposure assessment; and
- related sciences, e.g., synthetic biology, pharmacology, biotechnology, nanotechnology, biochemistry, biostatistics, PBPK modeling, computational toxicology, epidemiology, environmental fate, and environmental engineering and sustainability.
The SACC currently consists of 20 members. If necessary, a subcommittee will be formed to supplement the expertise of the 20 members.
The SACC was established by EPA in 2016 and operates in accordance with the Federal Advisory Committee Act (FACA) of 1972. The SACC supports activities under the Toxic Substances Control Act (TSCA), 15 U.S.C. 2601 et seq., the Pollution Prevention Act (PPA), 42 U.S. C. 13101 et seq., and other applicable statutes. The SACC provides independent scientific advice and recommendations to the EPA on the scientific and technical aspects of risk assessments, methodologies, and pollution prevention measures and approaches for chemicals regulated by TSCA.
Learn more about how EPA assesses chemical safety.
SACC Formation Process
Nominations for membership are solicited through publication in the Federal Register and through other sources. Any interested person or organization may nominate him or herself or any qualified individual to be considered for the SACC.
Nominations should include candidates who have demonstrated high levels of competence, knowledge, and expertise in scientific/technical fields relevant to chemical risk assessment methodologies and pollution prevention measures or approaches. To the extent feasible, the members will include representation of the following disciplines, including, but not limited to: human health and ecological risk assessment, biostatistics, epidemiology, pediatrics, physiologically-based pharmacokinetics (PBPK), toxicology, pathology, and chemical exposure to susceptible life stages and subpopulations (including women, children, and others). In addition to scientific expertise, members also have background and experience that will contribute to the diversity of scientific viewpoints on the committee, including professional experience in government, labor, public health, public interest, animal protection, industry, and other groups.